Company: PIII
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001832511-25-000013
Chunk: 90

Company: P3 Health Partners Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 90
---
)$63,250 Issuance of Class A common stock upon settlement of restricted stock units, net of shares withheld for tax— 5 — — — — — — Equity-based compensation— — — — — 1,463 — 1,463 Remeasurement adjustment to redeemable non-controlling interest from material ownership changes8,193 — — — — (8,193)— (8,193)Class A common stock warrants issued— — — — — 8,301 — 8,301 Net loss(23,303)— — — — — (20,362)(20,362)STOCKHOLDERS’ EQUITY, June 30, 2025$42,719 3,268 $— 3,919 $— $588,494 $(544,035)$44,459 

All periods presented have been retroactively adjusted to reflect the 1-for-50 reverse stock split effected on April 11, 2025. See Note 3 “Significant Accounting Policies” for further information.  

See accompanying notes to condensed consolidated financial statements.

P3 Health Partners Inc. | Q2 2025 Form 10-Q | 7

P3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

Six Months Ended June 30,20252024CASH FLOWS FROM OPERATING ACTIVITIES:Net loss$(87,911)$(78,380)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization42,135 43,232 Equity-based compensation3,271 3,073 Amortization of original issue discount and debt issuance costs402 (91)Mark-to-market adjustment of stock warrants(5,324)(8,889)Premium deficiency reserve(12,929)(2,397)Changes in operating assets and liabilities:Health plan receivable27,803 (34,762)Clinic fees, insurance, and other receivable(3,625)775 Prepaid expenses and other current assets(1,747)(4,865)Other long-term assets(14,464)60 Accounts payable, accrued expenses, and other current liabilities6,200